Searched for
DOXYCYCLINE HYCLATE
Alembic Pharma gets USFDA nod for generic drugDoxycycline Hyclate delayed-release tablets are indicated to reduce the development of drug resistant bacteria.- Market Movers: YES Bank on a high, Maruti falls, Lupin, Cadila gain; 46 stocks give ‘buy’ signalsHere is a lowdown of the movers and shakers of Wednesday’s session on Dalal Street.
- Sun, Dr Reddy's among 7 Indian pharma majors sued in US for price riggingThe lawsuit widens a complaint of price collusion filed in 2016, which is still pending in US courts after being first investigated in 2014.
- Zydus Cadila gets USFDA nod for 2 drugsThe group has more than 241 approvals, and so far filed over 340 abbreviated new drug applications (ANDAs) since it started filings in 2003...
- Alembic Pharma gets USFDA nod for its antibiotic capsulesThe approval from USFDA is for the company's abbreviated new drug application (ANDA) in the strengths of 50 mg and 100 mg, Alembic Pharma s...
- Sensex drops 215 pts as banks drag, Nifty breaks below 10,650Investors' risk appetite remained subdued ahead of the RBI's rate decision on Wednesday.
- Cadila Healthcare rises 2% on USFDA approval to antibiotic drugThis medication is also used for prophylaxis of malaria.
- Stocks in focus on June 4, 2018Here is a list of top stocks that are likely to be in focus in today's trading session.
- Zydus gets final nod from USFDA for anti-bacterial drugZydus Cadila is a global pharmaceutical company that develops, manufactures and markets a broad range of healthcare therapies. The group em...
- Lupin launches tablets in US to treat infectionsThe 75 mg and 150 mg tablets were launched after receiving the approval for the from the United States Food and Drug Administration (USFDA)...
- Top stocks in focus on 3 October 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
- Lupin gets USFDA nod to market anti-infections tabletsThe company has received final approval from the USFDA to market its Doxycycline hyclate tablets USP in the strength of 100 mg.
- What class action suit against Taro means for Sun PharmaAnalysts were jittered by the DOJ investigation of drug pricing, with some brokerages cutting down the forecast for the Indian pharma secto...
- US generics probe reveals startling detail of price fixing in Doxycycline and GlyburideA Bloomberg report said two executives of Heritage Pharma – the US arm of Indian drug maker Emcure - are preparing to plead guilty to price...
- US probe against generic drugs overblown: ExpertsThe DoJ has in the past probed multinational drug companies for inappropriate marketing practices but the scale of investigations against t...
- Taro drug pricing probe may widen to other generic drug makersResearch by IIFL shows several generic drug companies, including a few top Indian generic drug makers, effected steep price increases withi...
- Sun Pharma gets US subpoena over generic drugs pricingThe subpoena comes amid a wider probe by US regulators into steep increases in the prices of generic medicines in recent years.
- Sun Pharma slumps over 6% on USFDA import alert; doxycycline prices fallRanjit Kapadia an analyst at Centrum Broking doesn’t see more than 4-5 per cent revenue hit for the company due to import alert.
- Sun Pharma gains as subsidiary Taro inks drug pactElara Capital is of the view that current valuations of the company are rich and has maintained its ‘accumulate’ rating with target price o...
- Next generation of airport security to take off soonAirport security can no longer rely just on conventional screening methods.
Load More
